|
Mechanisms of Leukemogenesis in Down Syndrome |
5R01CA101774-18 |
CRISPINO, JOHN D |
NCI |
2020 |
|
Evaluation of myocardial targets to prevent anthracycline cardiotoxicity in children with Down Syndrome and Leukemia |
5R21CA245067-02 |
BLANCO, JAVIER G |
NCI |
2020 |
|
Applications of high resolution fMRI in ultra-high field (7T) in revealing developmental disorders underlying amblyopia |
1 R01 EY030434-01A1 |
NASR, SHAHIN |
NEI |
2020 |
|
Leveraging Maps and Computer Vision to Support Indoor Navigation for Blind Travelers |
5R01EY029033-03 |
COUGHLAN, JAMES M |
NEI |
2020 |
|
Discovery of susceptibility genes for Down syndrome-associated congenital heart defects using whole genome sequencing |
1 R03 HL156476-01 |
LESLIE, ELIZABETH JANE |
NHLBI |
2020 |
|
ARIZONA PRIDE-25: TRANSLATIONAL APPROACHES TO HEALTH DISPARITIES IN THE LUNG |
5R25HL126140-06 |
GARCIA, JOE G N |
NHLBI |
2020 |
|
Erroneous Coding of Developmental Disabilities as Underlying Cause of Death |
1 R03 AG065638-01 |
LANDES, SCOTT D |
NIA |
2020 |
|
Building Community Capacity for Disability Prevention for Minority Elders COVID-19 supplement |
3R01AG046149-07A1S2 |
ALEGRIA, MARGARITA |
NIA |
2020 |
|
Administrative Supplement to Communication Bridge: A person-centered Internet-based intervention for individuals with primary progressive aphasia |
3R01AG055425-03S1 |
ROGALSKI, EMILY J |
NIA |
2020 |
|
Nanochelation-Based Theranostics for Alzheimer Disease |
3R01HL143020-03S1 |
KIM, JONGHAN |
NIA |
2020 |